Tumor-targeting performance of recombinant antibody fragments. Results of biodistribution studies in nude mice bearing a subcutaneously implanted F9 murine teratocarcinoma, performed with radiolabeled scFv(L19) and scFv(D1.3). Tumor and blood levels are expressed as percent injected dose per gram (%ID/g).